Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Cilostazol Impurity 12-D11

Cilostazol Impurity 12-D11 is listed in the pharmaceutical impurity collection under CAS 1073608-13-5. Its represented structure has formula C20H25N5O2 and a calculated molecular weight of 378.52 g/mol.

2D chemical structure

2 H 2 H 2 H 2 H 2 H 2 H 2 H N N N N O N H O 2 H 2 H 2 H 2 H

Chemical identity

Catalog name
Cilostazol Impurity 12-D11
Common name
Cilostazol Impurity 12-D11
Chemical name
Not available
CAS
1073608-13-5
SMILES
[2H]C1([2H])C([2H])([2H])C([2H])([2H])C([2H])(n2nnnc2CCCCOc2ccc3[nH]c(=O)ccc3c2)C([2H])([2H])C1([2H])[2H]
InChI
InChI=1S/C20H25N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h9-12,14,16H,1-8,13H2,(H,21,26)/i1D2,2D2,3D2,6D2,7D2,16D
InChIKey
GHALECSGOJQOHW-SAGHCWGKSA-N
Associated API
Cilostazol

Record ID: A84f852bbf162

Computed properties

C20H25N5O2 Molecular formula
378.5201 g/molMolecular weight
378.2699 DaMonoisotopic exact mass
85.69 ŲTopological polar surface area
3.4215 Calculated LogP (Wildman–Crippen)
102.9407 cm³/molMolar refractivity (Wildman–Crippen)
5 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. The structure contains 11 isotopically specified atoms.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 6 12 18 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight378.520164.55
Calculated LogP (Wildman–Crippen)3.421569.55
Topological polar surface area85.6962.24
Hydrogen-bond acceptors565.12
Hydrogen-bond donors138.08
Rotatable bonds (strict)776.94

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC20H25N5O2dimensionless
Molecular weight378.5201g/mol
Monoisotopic exact mass378.2699Da
Topological polar surface area85.69Ų
Calculated LogP (Wildman–Crippen)3.4215dimensionless
Molar refractivity (Wildman–Crippen)102.9407cm³/mol
Hydrogen-bond acceptors5count
Hydrogen-bond donors1count
Rotatable bonds (strict)7count
Heavy atoms27count
Heteroatoms7count
Rings4count
Aromatic rings3count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles2count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles1count
Fraction of sp³ carbon atoms0.5fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms11count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area172.7466Ų
Valence electrons142count
Radical electrons0count
Bertz complexity1,375.2555index
Balaban J1.5125index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Cilostazol Impurity 12-D11

Qualification and safety assessment of Cilostazol Impurity 12-D11

Explore toxicological qualification of Cilostazol Impurity 12-D11 and ICH M7 mutagenic impurity assessment of Cilostazol Impurity 12-D11 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Cilostazol Impurity 12-D11 and acceptable intake and limit justification for Cilostazol Impurity 12-D11. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Cilostazol Impurity 12-D11

Explore Altox services and software through the Altox Pharma-Hub.